Label: WHIMELA SHINING IMPLANT- glycerin cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated January 3, 2020

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Glycerin

  • INACTIVE INGREDIENT

    Water, Niacinamide, Adenosine, Butylene Glycol, etc.

  • PURPOSE

    Skin Protectant

  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children

  • INDICATIONS & USAGE

    How To Use: Gently shake and spray proper amount to desired area. Also use it frequently onto the dried skin and irritated skin.

  • WARNINGS

    Precautions

    1. If the cosmetic causes red rash, swollenness or itching by exposure to sunlight during the use, you are advised to stop using it immediately and you may consult a pharmacist or a doctor

    2. It is not advised to use the cosmetic on the skin where you have scars

    3. Precautions for storage

    ⓐ Keep it out of infants or children’s reach

    ⓑ Keep it out of the place where exposure to direct sunlight exists

  • DOSAGE & ADMINISTRATION

    for external use only


  • PRINCIPAL DISPLAY PANEL

    1

  • INGREDIENTS AND APPEARANCE
    WHIMELA SHINING IMPLANT 
    glycerin cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72368-0002
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN8 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    NIACINAMIDE (UNII: 25X51I8RD4)  
    WATER (UNII: 059QF0KO0R)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    ADENOSINE (UNII: K72T3FS567)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72368-0002-150 g in 1 JAR; Type 0: Not a Combination Product06/01/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34706/01/2018
    Labeler - Threedayslove Co., Ltd. (693724138)
    Registrant - Threedayslove Co., Ltd. (693724138)
    Establishment
    NameAddressID/FEIBusiness Operations
    Threedayslove Co., Ltd.693724138manufacture(72368-0002) , pack(72368-0002) , label(72368-0002)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!